Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors

NCT06625190 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT06625190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06625190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors
Lead sponsor
University of Florida
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 11, 2026
Completion date
February 28, 2030
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar soft part sarcoma, chordoma, clear cell sarcoma, desmoplastic small round cell tumor, epithelioid sarcoma, ewing sarcoma, myoepithelial tumor, neuroblastoma, osteosarcoma, peripheral nerve sheath tumors, rhabdoid tumor, rhabdomyosarcoma, synovial sarcoma, wilms tumor